NDC product
Ampicillin and Sulbactam
NDC 0409-2689 · Hospira, Inc
Key facts
| Product NDC | 0409-2689 |
|---|---|
| Proprietary name | Ampicillin and Sulbactam |
| Nonproprietary name | Ampicillin sodium and Sulbactam sodium |
| Substances | AMPICILLIN SODIUM, SULBACTAM SODIUM |
| Dosage form | INJECTION, POWDER, FOR SOLUTION |
| Route | INTRAVENOUS |
| Labeler | Hospira, Inc |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Application number | ANDA065310 |
| Pharmacologic classes | Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA] |
| Marketing start | Jul 25, 2006 |
| Marketing end | Oct 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory